Xos (Xylooligosaccharides) for Immune Function

Research suggests that XOS supplementation may support immune function across a range of animal models, with studies in piglets, broiler chickens, laying hens, fish, and even kittens consistently reporting improvements in antibody levels, anti-inflammatory cytokine profiles, gut barrier integrity, and resistance to infectious challenge. The available evidence comes primarily from controlled animal feeding trials rather than human clinical studies, and the proposed mechanisms center on XOS selectively enriching beneficial gut bacteria — particularly bifidobacteria — which in turn produce short-chain fatty acids that appear to modulate inflammatory signaling and immune cell activity. One study in broiler chickens showed mixed findings, noting that XOS alone produced less pronounced immune organ development compared to a butyrate supplement, and no clear synergistic benefit was observed when the two were combined, suggesting that effects may depend on the specific immune outcome measured and the dietary context. A 2025 review acknowledges the promise of this research but emphasizes that robust human clinical trials remain limited, and conclusions about immune benefits in people should be drawn cautiously until that evidence base matures.